Personal information

Countries

Türkiye

Activities

Collapse all

Employment (1)

Institute of Oncology, Istanbul University: Istanbul, İSTANBUL, TR

1996-08-07 to present | MD Prof (Medical Oncology)
Employment
Source: Self-asserted source
Mert Basaran

Works (5)

Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort

Journal of Chemotherapy
2024-02-17 | Journal article
DOI: 10.1080/1120009X.2023.2215090
Contributors: Kübra Özkaya Toraman; Rasim Meral; Ahmet Nafiz Karadeniz, (Emeritus); Gizem Kaval; Mert Başaran; Meltem Ekenel; Musa Altun
Source: check_circle
Crossref

Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma

Journal of Chemotherapy
2023-05-19 | Journal article
DOI: 10.1080/1120009X.2022.2104295
Contributors: Izzet Dogan; Ayca Iribas; Melin Aydan Ahmed; Mert Basaran
Source: check_circle
Crossref

Baş ve Boyun Sarkomlarının Klinik Gidişleri ve Özellikleri (Tek Merkez Deneyimi)

Batı Karadeniz Tıp Dergisi
2022-12-27 | Journal article
DOI: 10.29058/mjwbs.1061947
Contributors: Metin PEHLİVAN; Ayça İRİBAŞ; Bilge BİLGİÇ; Mert BAŞARAN; Meltem EKENEL
Source: check_circle
Crossref

Yumuşak Doku Sarkomlarında Adjuvan Tedavi (Tek Merkez Deneyimi)

Batı Karadeniz Tıp Dergisi
2022-12-27 | Journal article
DOI: 10.29058/mjwbs.1061890
Contributors: Metin PEHLİVAN; Ayça İRİBAŞ; Bilge BİLGİÇ; Mert BAŞARAN; Meltem EKENEL
Source: check_circle
Crossref

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center

Namık Kemal Tıp Dergisi
2022-12-15 | Journal article
DOI: 10.4274/nkmj.galenos.2022.78942
Contributors: Ferhat FERHATOĞLU; Nail PAKSOY; Mert BAŞARAN
Source: check_circle
Crossref
How many people are using ORCID?